Adaptive Biotechnologies (ADPT) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $28.06 --0%
EPS Growth %: -266.7%
Financial Fact:
Net income (loss): -65.15M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -266.7%
Financial Fact:
Net income (loss): -65.15M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $37.92 million versus the consensus estimate of $42.96 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
- Worthington Industries (WOR) Tops Q1 EPS by 7c
- Oppenheimer Starts Collegium Pharmaceutical (COLL) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
